
Two Oregon women filed separate lawsuits one week apart accusing the same Kaiser Permanente podiatrist of injecting rubbing alcohol instead of a numbing drug before ripping out toenails.
Story Highlights
- Two women allege a Kaiser Permanente podiatrist injected 70% isopropyl alcohol instead of lidocaine during toenail procedures at the same facility, one week apart.
- Both complaints describe severe pain during the procedures and claim lasting injuries, including burns, tissue loss, and chronic pain.
- The lawsuits seek multimillion-dollar damages; Kaiser says patient safety is its top priority and it reviews reported events.
- The cases echo a broader pattern of “wrong drug” errors seen in patient-safety research, though each claim will be decided in court.
What The Lawsuits Say Happened
Media reports say the first patient, identified as Young, underwent a toenail procedure at Kaiser Permanente’s Westside Medical Center in Hillsboro on January 22, 2026. Her complaint alleges the podiatrist injected about 4 cubic centimeters of 70% isopropyl rubbing alcohol instead of lidocaine, then removed the nail as she cried and screamed in pain. A second patient, Sarah Blackman, alleges the same doctor injected 4 milliliters of alcohol into each toe during a January 29, 2026 procedure at the same facility.
Both complaints describe immediate, intense pain and an absence of effective numbing during the nail removals. Reports summarizing the filings say the women later suffered chemical burns, tissue death, disfigurement, and ongoing nerve pain that makes walking hard. One report quotes language likening the experience to “torture,” reflecting the plaintiffs’ characterization in court filings and interviews, not a legal finding. The complaints seek multimillion-dollar damages for medical costs, pain, and long-term effects.
Who Is Involved And What They Say
The lawsuits name the podiatrist, identified in reports as Dr. Colin Mizuo, and Kaiser Permanente. Outlets report that Dr. Mizuo has not publicly commented on the allegations or replied to requests for comment. Kaiser has stated that patient safety is its highest priority and that it reviews care and takes action as needed when issues are identified. One outlet reported that Mizuo had since left Kaiser; public records cited in that report showed no board discipline at that time.
The two filings came within days of each other and describe similar conduct, the same doctor, the same Hillsboro facility, and comparable injuries. That timing and detail may matter if a court weighs possible patterns in process or labeling errors. The complaints themselves, not yet tested at trial, will trigger discovery steps that could surface medication records, inventory logs, or other evidence about what was in the syringes that day.
Why This Resonates Beyond One Clinic
Medication mistakes are a known safety risk. Research reviews find “wrong drug” errors make up a meaningful share of reported medication errors across care settings. Another review estimates that adverse drug events occur in about 2% to 6% of hospital admissions, with thousands of deaths nationwide tied to medication errors each year, though estimates vary by method. These cases echo those base rates in a vivid, personal way that is rare and alarming to patients.
A second woman alleges in a $23 million lawsuit that the same Kaiser Permanente doctor injected rubbing alcohol into her toes before removing a toenail. https://t.co/06JZXM6Uq6
— KGW News (@KGWNews) November 11, 2026
For families on the right and the left, the core worry is the same: systems that are supposed to protect people can fail them. When patients say they begged for help and the pain continued, it strikes a nerve for anyone who feels the “experts” and big institutions have stopped listening. These lawsuits are civil claims, not verdicts, but they raise basic questions about labeling, staffing, training, and accountability that every hospital should address before harm occurs.
What To Watch Next
Courts will sort the claims and defenses, but key facts could arrive sooner. Discovery could reveal electronic health records, medication-administration notes, pharmacy logs, and supply-room data that show whether lidocaine or alcohol was drawn and used. Testimony from nurses, medical assistants, pharmacy staff, and clinic leaders could clarify if this was a single lapse or a broader workflow failure. Kaiser’s internal review and any state actions will also shape outcomes and public trust.
Sources:
washingtontimes.com, wthr.com, kptv.com, oregonlive.com, koin.com, newscentermaine.com, medpagetoday.com, medindia.net, chronline.com, lawandcrime.com













